Individualized Dialysis Prescription: Setting Up Profiling and Patient Benefits
Dialysis profiling should be prescribed by tailoring the ultrafiltration rate, treatment time, dialysate sodium concentration, and dialysis frequency to each patient's specific clinical parameters—including interdialytic weight gain, blood pressure control, residual kidney function, and metabolic needs—to minimize hemodynamic instability, reduce intradialytic symptoms, and optimize volume management while achieving adequate solute clearance.
Core Components of Individualized Dialysis Prescription
Treatment Time and Ultrafiltration Rate
Prescribe a minimum of 3 hours per session for patients with residual kidney function <2 mL/min undergoing thrice-weekly hemodialysis 1.
Extend treatment time or add sessions for patients with:
Set the ultrafiltration rate to balance achieving euvolemia and adequate blood pressure control while minimizing hemodynamic instability and intradialytic symptoms 1.
Dialysate Sodium Individualization
Individualized dialysate sodium concentration represents a critical profiling strategy that directly impacts fluid management and hemodynamic stability.
Calculate dialysate sodium by setting it 0-2 mEq/L below the patient's average pre-dialysis serum sodium level (multiplied by 0.95) 2.
This approach reduces interdialytic weight gain by 21% (from 2.91 kg to 2.29 kg), decreases thirst scores, and lowers intradialytic hypotension episodes 2.
In patients with uncontrolled baseline blood pressure, individualized dialysate sodium reduces pre-dialysis systolic BP by 15.6 mmHg and diastolic BP by 6.5 mmHg 2.
Patients receiving individualized dialysate sodium have 3.6 times greater odds of achieving lower interdialytic weight gain compared to standard dialysate sodium (138 mmol/L) 3.
Avoid standardized dialysate sodium for all patients, as this fails to account for individual sodium setpoints and can promote excessive interdialytic fluid ingestion 4, 2.
Solute Clearance Targets
Target single pool Kt/V of 1.4 per session for thrice-weekly hemodialysis, with minimum delivered spKt/V of 1.2 1.
For non-thrice-weekly schedules, target standard Kt/V of 2.3 volumes per week with minimum delivered dose of 2.1, including contributions from ultrafiltration and residual kidney function 1.
In patients with significant residual kidney function (Kru), reduce dialysis dose only if Kru is measured within 3 months to avoid underdialysis 1.
Membrane Selection
- Use biocompatible high-flux or low-flux hemodialysis membranes for intermittent hemodialysis 1.
Alternative Dialysis Modalities for Specific Populations
Frequent Hemodialysis Options
Offer in-center short frequent hemodialysis (>3 sessions/week) as an alternative to conventional thrice-weekly hemodialysis after discussing quality of life benefits and risks 1.
Inform patients that frequent hemodialysis carries increased risk of vascular access procedures and potential for hypotension 1.
Consider home long hemodialysis (6-8 hours, 3-6 nights/week) for patients preferring this for lifestyle considerations 1.
Counsel patients on home long frequent hemodialysis about possible increased vascular access complications, caregiver burden, and accelerated decline in residual kidney function 1.
Pregnancy-Specific Recommendations
- Prescribe long frequent hemodialysis (in-center or home) for pregnant women with end-stage kidney disease 1.
Patient-Specific Factors Requiring Prescription Adjustment
Volume and Blood Pressure Management
Combine dietary sodium restriction with adequate sodium/water removal during hemodialysis to manage hypertension, hypervolemia, and left ventricular hypertrophy 1.
Adjust dry weight based on clinical assessment of volume status, avoiding reliance solely on kinetic models 1.
Nutritional and Metabolic Considerations
Incorporate body surface area (BSA), albumin, pre-albumin, cholesterol, Body Mass Index, and Malnutrition Inflammation Score when determining dialysis intensity 5.
For patients with BSA <1.7 m², consider lower dialysate volumes; for BSA >2.0 m², increase volumes accordingly 6.
Comorbidity-Based Adjustments
In younger, lower-risk patients, prioritize efficiency (kinetic adequacy targets) 5.
In older, high-comorbidity patients, prioritize tolerance over efficiency—focus on stable metabolic balance with minimal dialysis-related morbidity 5.
Consider Charlson Comorbidity Index, dialysis vintage, and life expectancy when determining treatment intensity 5.
Clinical Benefits of Individualized Dialysis Profiling
Hemodynamic Stability
Individualized ultrafiltration profiling reduces intradialytic hypotension and cramping episodes 7.
Longer dialysis sessions (5 vs 4 hours) provide greater hemodynamic stability and fewer hypotensive episodes, particularly in patients >65 years 1.
Fluid Management
Individualized dialysate sodium reduces interdialytic thirst and weight gain, improving adherence to fluid restrictions 2.
Patients achieve target weights more consistently with sodium gradient-based prescriptions 3.
Quality of Life and Symptom Burden
Tailored dialysis prescriptions reduce post-dialysis fatigue and improve overall quality of life 8, 5.
Individualized approaches decrease the burden of dialysis-related symptoms including cramping, hypotension, and fatigue 8.
Cardiovascular Protection
Adequate sodium and water removal combined with dietary sodium restriction reduces left ventricular hypertrophy 1.
Controlled ultrafiltration rates minimize acute cardiac events and long-term cardiovascular damage 1.
Common Pitfalls and How to Avoid Them
Standardized Prescriptions
- Avoid using "one size fits all" dialysis prescriptions—this approach fails to account for individual variations in sodium setpoint, volume status, and metabolic needs 5, 4.
Inadequate Monitoring
Measure residual kidney function every 3 months when using it to reduce dialysis dose, as failure to do so risks underdialysis 1.
Monitor pre-dialysis serum sodium levels regularly (at least three measurements) before calculating individualized dialysate sodium 2.
Ignoring Patient-Specific Factors
Do not prescribe dialysis based solely on Kt/V targets without considering blood pressure control, volume status, metabolic parameters, and symptom burden 1.
Account for vascular access type (fistula vs catheter) and functionality when determining treatment parameters 5.
Premature Dialysis Initiation
- Base the decision to initiate dialysis on uremic symptoms, protein-energy wasting, and inability to manage metabolic abnormalities—not solely on GFR thresholds 1.